Dr. Graeme Woodworth is opening the door to a promising new treatment for aggressive malignant brain cancer.Focused ultrasound activating bubbles in the blood allow targeted chemotherapy to cross the blood-brain barrier.Graeme F. Woodworth, MD, FACS, chief of neurosurgery at the University of Maryland Medical Center and the Howard M. Eisenberg, MD Distinguished Professor of Neurosurgery and chair of the Department of Neurosurgery at the University of Maryland School of Medicine, is advancing the treatment of glioblastoma, the most common and deadly primary brain cancer in adults. More than 14,000 Americans are diagnosed with glioblastoma each year. Patients typically survive only 12 to18 months after a diagnosis because the cancer quickly spreads throughout the brain.His research is funded by grants from the National Cancer Institute and the National Institute of Neurological Disorders and Stroke, both within the National Institutes of Health.Learn more: https://www.umaryland.edul/breakthroughs#CancerResearch #braincancer #nihresearch #NIH #NINDS #medicalbreakthrough